GGrantIndex
Sort

48,018 grants matching immunotherapy

Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell Level

$658,549
Warren Phipps · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA

Systems analyses of induction and maintenance of immunity to SARS-CoV-2 vaccination in kidney transplant recipients receiving mycophenolate mofetil immunotherapy

$658,538
Elaine F Reed · University Of California Los Angeles · U01 · FY2025 · AI

Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases

$658,526
Ouri Cohen · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA

Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy

$658,506
Dan Landau · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA

Identifying therapeutic pathways targeting medulloblastoma-immune cell interactions

$658,459
Ernest Fraenkel · Massachusetts Institute Of Technology · U01 · FY2022 · CA

Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer

$658,454
Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Development and Evaluation of Advanced Non-Contrast Perfusion MRI for Monitoring Treatment Response in Brain Metastases

$658,432
Qin Qin · Johns Hopkins University · R01 · FY2023 · CA

Engineering T Cell Adoptive Therapy for Glioblastoma

$658,407
Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2023 · NS

Biological and social determinants of psychosocial sequelae in advanced head and neck cancer survivors receiving immunotherapy

$658,403
Canhua Xiao · Emory University · R01 · FY2025 · CA

Developing Safe and Effective GD2-CAR T Cell Therapy for Diffuse Midline Gliomas

$658,390
Crystal Mackall · Stanford University · R01 · FY2023 · CA

The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity

$658,369
David G Denardo · Washington University · U01 · FY2023 · CA

Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk

$658,328
Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA

Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk

$658,328
Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Developing ultrasound contrast agents and signal processing for structural and functional imaging in type 1 diabetes

$658,293
Richard Kp Benninger · University Of Colorado Denver · R01 · FY2024 · DK

Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer

$658,205
Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Clinical production of viral vectors for cancer gene therapy

$658,126
Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

VPS72 controls Treg cell stability and adaptation to tumor microenvironment

$658,092
Qing-Sheng Mi · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2023 · CA

Early response to radiotherapy and immunotherapy in rectal cancer: an integrated molecular, cellular, and spatial approach

$658,048
Todd A Aguilera · Ut Southwestern Medical Center · R01 · FY2025 · CA

The role of brain resident T cells in Alzheimer's disease

$657,966
Pamela Rosato · Dartmouth College · R01 · FY2022 · AG

Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.

$657,955
Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2019 · CA

Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments

$657,944
Calvin J Kuo · Stanford University · R01 · FY2021 · CA

In Vivo Hematopoietic Stem Cell Gene Therapy of Beta-Thalassemia and Sickle Cell Disease

$657,943
Andre Michael Lieber · University Of Washington · R01 · FY2021 · HL

In Vivo Hematopoietic Stem Cell Gene Therapy of Beta-Thalassemia and Sickle Cell Disease

$657,943
Andre Michael Lieber · University Of Washington · R01 · FY2022 · HL

In Vivo Hematopoietic Stem Cell Gene Therapy of Beta-Thalassemia and Sickle Cell Disease

$657,943
Andre Michael Lieber · University Of Washington · R01 · FY2023 · HL

Beyond Binding: Personalized Multi-omic Neoantigen Identification

$657,934
Rachel Karchin · Johns Hopkins University · R01 · FY2025 · CA